Live from the NIH registry
Studies recruiting near Victorville right now
Top 25 of 49 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Rialto, California (29.1 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Rialto, California (29.1 mi)
· Sponsor: 89bio, Inc.
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 751 participants sought
Om Research, LLC - Victorville - Site Number: 8400022 — Victorville, California (3.6 mi)
· Sponsor: Sanofi
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
Sleep-Disordered Breathing, Sleep Apnea Syndromes in Children
N/A
Interventional 160 participants sought
Pediatric Ear, Nose, and Throat Surgery and Audiology — San Bernardino, California (29.2 mi)
· Sponsor: Loma Linda University
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
Lupus Erythematosus, Systemic, Lupus Nephritis
Phase 2
Interventional 179 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Novartis Pharmaceuticals
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Velocity Clinical Research — San Bernardino, California (29.2 mi)
· Sponsor: vTv Therapeutics
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Om Research — Victorville, California (3.6 mi)
· Sponsor: Eccogene
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Phase 3
Interventional 600 participants sought
Velocity Clinical Research- Banning — San Bernardino, California (29.2 mi)
· Sponsor: Pfizer
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
Hepatic Impairment, Cirrhosis
Phase 1
Interventional 144 participants sought
Inland Empire Clinical Trials — Rialto, California (29.1 mi)
· Sponsor: Vir Biotechnology, Inc.
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Victorville, California (3.6 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Victorville, California (3.6 mi)
· Sponsor: 89bio, Inc.
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
Kidney Disease, Peritoneal Dialysis (PD)
N/A
Observational 125 participants sought
Desert Cities Dialysis — Victorville, California (3.6 mi)
· Sponsor: Bodyport Inc.
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Inland Empire Clinical Trials, LLC — Rialto, California (29.1 mi)
· Sponsor: Boehringer Ingelheim
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Phase 2
Interventional 240 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Novartis Pharmaceuticals
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Site US10008 — San Bernardino, California (29.2 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
Overweight or Obesity and Elevated Liver Fat
Phase 2
Interventional 180 participants sought
Inland Empire Liver Foundation — Rialto, California (29.1 mi)
· Sponsor: Amgen
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Om Research LLC — Apple Valley, California (9.7 mi)
· Sponsor: Hoffmann-La Roche
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
Moderate Hepatic Impairment
Phase 1
Interventional 20 participants sought
Research Site — Rialto, California (29.1 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Apple Valley, California (9.7 mi)
· Sponsor: AstraZeneca
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Velocity Clinical Research -San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Velocity Clinical Research - San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Boehringer Ingelheim
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)
Chronic Hepatitis B Infection
Phase 2
Interventional 200 participants sought
Aligos Investigational Site — Rialto, California (29.1 mi)
· Sponsor: Aligos Therapeutics
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
Hepatic Impairment
Phase 1
Interventional 28 participants sought
Research Site — Rialto, California (29.1 mi)
· Sponsor: AstraZeneca
A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems
Healthy, Hepatic Impairment
Phase 1
Interventional 32 participants sought
Inland Empire Clinical Trials, LLC — Rialto, California (29.1 mi)
· Sponsor: Boehringer Ingelheim